Anup Malani : Publications
Book Sections
"Economics of Infectious Diseases." In The Oxford Handbook of Health Economics, edited by Sherry Glied and Peter C. Smith, 2011 (with Ramanan Laxminarayan).
"The Welfare Effects of FDA Regulation of Drugs." In The Handbook of Pharmaceutical Economics, edited by Patricia Danzon and Sean Nicholson, 2010 (with Tomas Philipson).
"Comment on Chapter 3, by Burman, Garrett, and Khitatrakun " In Conference on Taxes and Health Insurance: Analysis and Policy, edited by Burman and Helms. Brookings, 2008.
"Expectations Mediate Objective Physiological Placebo Effects." In vol. 20 of Neuroeconomics, Advances in Health Economics and Heatlh Services Research, edited by Dan Houser and Kevin McCabe. Emerald Publishing Group, 2008 (with Dan Houser).
"Firm Behavior in the Non-Profit Sector: A Synthesis and Empirical Evaluation." In The Governanace of Not-for-Profit Firms, edited by Edward Glaeser. NBER/University of Chicago Press, 2003.
Journal Articles
“Incentives for Reporting Infectious Disease Outbreaks.” 46 Journal of Human Resources 176–202 (2011) (with Ramanan Laxminarayan).
"Ambiguity about Ambiguity: An Empirical Inquiry into Legal Interpretation." 2 Journal of Legal Analysis 257 (2010) (with Ward Farnsworth and David Guzior).
"Clinical and Economic Outcomes Attributable to Healthcare-Associated Sepsis and Pneumonia." Feb. 22 Archives of Internal Medicine (2010) (with Michael Eber, Ramanan Laxminarayan, and Eli N. Perencevich).
"Corporate Philanthropy and the Market for Altruism." 109(5) Columbia Law Review 571 (2009) (with M. Todd Henderson).
"Antibiotic Overuse: The Influence of Social Norms." 207(2) Journal of the American College of Surgeons 265 (2008) (with T. Buchman, J. Dushoff, M. Effron, P. Ehrlich, S. Fitzpatrick, R. Laxminarayan, B. Levin, S. Levin, M. Lipsitch, C. Nemeroff, S. Otto, V. Patel, and J. Solomkin).
"Does Non-Profit Status Signal Quality?" 37 Journal of Legal Studies 551 (2008) (with Guy David).
"Regulation with Placebo Effects." 58 Duke Law Journal 411 (2008).
"Valuing Laws as Local Amenities." 121(5) Harvard Law Review 1273 (2008).
"The Case for For-Profit Charities." 93 Virginia Law Review 2017 (2007) (with Eric Posner).
"Introduction: Current Research in Medical Malpractice Liability." 36 Journal of Legal Studies S1 (2007).
"Habeas Settlements." 92 Virginia Law Review 1 (2006).
"Identifying Placebo Effects with Data from Clinical Trials." 114 Journal of Political Economy 236 (2006).
"Ethical Issues in Research in Complementary and Alternative Medicine." 291 Journal of the American Medical Association 2192 (2004) (letter to the editor; with Harvey Cantor).
"The Political Economy of Property Exemption Laws." 47 Journal of Law and Economics 19 (2004) (with Richard Hynes and Eric A. Posner).
"Measurement Errors: A Principal Investigator-Agent Approach." 91 Journal of Econometrics 273 (1999) (with Tomas Philipson).
"The Scope of Criminal Forfeiture under RICO: The Appropriate Definition of 'Proceeds'." 66 University of Chicago Law Review 1289 (1999).
"Determinants of Direct Foreign Investment and Its Connection to Trade." 5 UNCTAD Review 29 (1994) (with Gary Hufbauer and Darius Lakdawalla).
Newspaper Articles
"Push for More Trials May Hurt Patients." Washington Examiner, July 21, 2010 (with Tomas Philipson).
"Beyond Swine Flu: Superbugs." Chicago Tribune, June 7, 2009, p. 29.
Magazine Articles
"Pay-for-delay or pay-for-innovation?" Forbes Online, July 15, 2010.
"The Right Combination of Carrots and Sticks." Resources, Fall 2009 (with Ramanan Laxminarayan).
"Capitalism 2.0." Forbes.com, March 10, 2008.
Papers (Monographs)
"Extending the Cure: Policy Responses to the Growing Threat of Antibiotic Resistance." Resources for the Future, 2007 (with Ramanan Laxminarayan, assisted by David Howard and David Smith).
"The Political Economy of Property Exemption Laws." John M. Olin Law & Economics Working Paper, no. 136. University of Chicago Law School, 2001 (with Richard Hynes and Eric A. Posner).
Working Papers
"Controlling Avian Influenza in Chickens." April 2007 (with Maciek Boni, Abraham Wickelgren, and Ramanan Laxminarayan).
"Patient Enrollment in Medical Trials: Selection Bias in a Randomized Experiment." April 2007.
"Employing Medicare and Medicaid to Control Resistance." April 2006.
"Expectations Mediate Objective Physiological Placebo Effects." March 2006 (with Dan Houser).
"Rational Crises." June 2006 (with Albert Choi).
"Supply-Side Strategies for Tackling Antibiotic Resistance." April 2006.
"Surveillance and Reporting of Disease Outbreaks: Private Incentives and WHO Policy Levers." February 2006 (with Ramanan Laxminarayan).
"Bayesian Statutory Interpretation." January 2005.
"Do Golden Parachutes Hurt Shareholders." April 2005 (with Rajesh Aggarwal).
"Forget Quality: Do Non-Profits Even Signal Their Status?", September 2005 (with Guy David).
"Are Non-Profit Firms For-Profits in Disguise? Evidence from the Nursing Home Industry." September 2004 (with Albert Choi).
"Assessing the Merits of Reallocation under Joint and Several Liability, with an Application to Asbestos Litigation." August 2004 (with Charles Mullin).
"The Option Value of New Therapeutics." October 2004 (with Feifang Hu).
"Does the Felony-Murder Rule Deter Crime? Evidence from FBI Crime Data." January 2002.
"Legal Regulation of Information Problems in Healthcare Markets." September 2001.
Thesis/Dissertation
"Placebo Effects, Self-Selection, and the External Validity of Clinical Trials." PhD dissertation, University of Chicago, 2003.
